Home > Drug Search >
  • company_query: Amplyx
  •   > 
Drug Filter
Category:
chemistry (11) biology (28)
Status:
Approved (3) Phase Ⅲ (5) Phase Ⅱ (16) Phase Ⅰ (15)
Clinical Stage:
Pending (7) Active (25) Discontinued (4)
Bio-Type:
Gene therapy (4) Cell therapy (2) Vaccine (7) Allergen extract (1) Recombinant polypeptide (1) Recombinant cytokines (6) Recombinant hormone (1) Other recombinant protein (1) Whole antibody (4)
Indication:
Non-alcoholic steatohepatitis (1) Actinic keratosis (AK) (1) Anemia (1) Atopic dermatitis (1) Bladder cancer (1) Breast cancer (1) Cerebral vasospasm (1) Metachromatic leukodystrophy (1) Neuronal ceroid lipofuscinoses (1) Diabetic macular edema (1) Eye disorders (1) Growth hormone deficit (1) Cytomegalovirus infections (1) HBV infection (1) HCV infection (2) Hepatocellular carcinoma (HCC) (1) Timothy grass pollen-induced allergic rhinitis (1) Hyperlipidemia (1) Inflammatory bowel disease (1) Melanoma (2) Non small cell lung cancer (NSCLC) (1) Non-alcoholic fatty liver disease (NAFLD) (1) Non-Hodgkin’s lymphoma (NHL) (1) Peptic ulcer (1) Prostate cancer (1) Rheumatoid arthritis (RA) (1) Solid tumours (2) Thrombocytopenia (1) Genital herpes (1) Fungal infection (1) Pain (1) Hemophilia B (1) Neutropenia (2) Retinal vein occlusion (1) Staphylococcal infection (1) Glioblastoma (1) Allergic asthma (1) Diffuse large B cell lymphoma (1) Bacterial infection (2) Human papillomavirus infections (HPV) (1) Cerebral haemorrhage (1) Hypersensitivity (2)
Aprv. Year:
2015 (1) 2016 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top